Jennifer Nelson to Product Surveillance, Postmarketing
This is a "connection" page, showing publications Jennifer Nelson has written about Product Surveillance, Postmarketing.
Connection Strength
2.054
-
Leveraging the entire cohort in drug safety monitoring: part 1 methods for sequential surveillance that use regression adjustment or weighting to control confounding in a multisite, rare event, distributed data setting. J Clin Epidemiol. 2019 08; 112:77-86.
Score: 0.631
-
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
Score: 0.406
-
Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:62-71.
Score: 0.378
-
Methods for observational post-licensure medical product safety surveillance. Stat Methods Med Res. 2015 Apr; 24(2):177-93.
Score: 0.376
-
Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association. Pharmacoepidemiol Drug Saf. 2016 09; 25(9):973-81.
Score: 0.129
-
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
Score: 0.110
-
A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:282-90.
Score: 0.024